Search Results - "Pipeling, M. R."

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    High‐Quality CMV‐Specific CD4+ Memory Is Enriched in the Lung Allograft and Is Associated With Mucosal Viral Control by Akulian, J. A., Pipeling, M. R., John, E. R., Orens, J. B., Lechtzin, N., McDyer, J. F.

    Published in American journal of transplantation (01-01-2013)
    “…The maintenance of CMV‐specific T cell memory in lung transplant recipients (LTRs) is critical for host defense and allograft durability, particularly in…”
    Get full text
    Journal Article
  2. 2

    Immunotherapy with vaccines combining MHC class II/CD80+ tumor cells with interleukin-12 reduces established metastatic disease and stimulates immune effectors and monokine induced by interferon γ by PULASKI, B. A, CLEMENTS, V. K, PIPELING, M. R, OSTRAND-ROSENBERG, S

    Published in Cancer Immunology, Immunotherapy (01-04-2000)
    “…Because they are difficult to treat, animal models of widespread, established metastatic cancer are rarely used to test novel immunotherapies. Two such mouse…”
    Get full text
    Journal Article
  3. 3

    Successful Treatment of Trichosporon mucoides Infection with Fluconazole in a Heart and Kidney Transplant Recipient by Nettles, Richard E., Nichols, Lynette S., McGuinn, Katherine Bell, Pipeling, Matthew R., Scheel, Paul J., Merz, William G.

    Published in Clinical infectious diseases (15-02-2003)
    “…Trichosporon species are an emerging cause of infection, particularly among transplant recipients. We report what we believe to be the first case of successful…”
    Get full text
    Journal Article
  4. 4

    Cell-based vaccines for the stimulation of immunity to metastatic cancers by Ostrand-Rosenberg, Suzanne, Pulaski, Beth A., Clements, Virginia K., Qi, Ling, Pipeling, Matthew R., Hanyok, Laura A.

    Published in Immunological reviews (01-08-1999)
    “…We are developing vaccines for inducing immunity lo metastatic cancers. Although primary tumors are frequently cured by surgery, chemotherapy, or radiation…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Acute Kidney Injury Increases Mortality After Lung Transplantation by George, Timothy J., MD, Arnaoutakis, George J., MD, Beaty, Claude A., MD, Pipeling, Matthew R., MD, Merlo, Christian A., MD, MPH, Conte, John V., MD, Shah, Ashish S., MD

    Published in The Annals of thoracic surgery (01-07-2012)
    “…Background Acute kidney injury requiring renal replacement therapy (RRT) is associated with increased mortality after cardiac surgery. Studies examining the…”
    Get full text
    Journal Article
  7. 7

    Immunotherapy with vaccines combining MHC class II/CD80 super(+) tumor cells with interleukin-12 reduces established metastatic disease and stimulates immune effectors and monokine induced by interferon by Pulaski, BA, Clements, V K, Pipeling, M R, Ostrand-Rosenberg, S

    Published in Cancer Immunology, Immunotherapy (01-01-2000)
    “…Because they are difficult to treat, animal models of widespread, established metastatic cancer are rarely used to test novel immunotherapies. Two such mouse…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Serial monitoring of exhaled nitric oxide in lung transplant recipients by Gashouta, Mohamed A., MD, Merlo, Christian A., MD, MPH, Pipeling, Matthew R., MD, McDyer, John F., MD, Hayanga, J.W. Awori, MD, MPH, Orens, Jonathan B., MD, Girgis, Reda E., MD

    “…Background Exhaled nitric oxide (FeNO), a marker of airway inflammation, is often elevated in lung transplant recipients (LTxRs) with acute rejection or…”
    Get full text
    Journal Article
  10. 10

    “Still” Ill? by Wung, Peter K., MD, Pipeling, Matthew R., MD, Wigley, Fredrick M., MD

    Published in The American journal of medicine (01-06-2008)
    “…Wung et al describe the case of a 59-year-old Caucasian man with daily high fevers, drenching night sweats, malaise, and a profound 45-lb weight loss. He also…”
    Get full text
    Journal Article